Lyell Immunopharma, Inc. LYEL Q2 2025 earnings
Reported August 12, 2025 · Before market open
Revenue$8.0KBeat by $4.0K
EPS-$2.89Beat by $0.91
Revenue estimate$4.0K
EPS estimate-$3.80
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$4.6K
EPS estimate-$2.02
Versus estimates
Revenue
Q1 2026$2.0KMiss by $1.0KQ4 2025$6.0KMiss by $9.3KQ3 2025$15.0K
Q2 2025$8.0KBeat by $4.0K
Q1 2025$7.0KQ4 2024$11.0KDiluted EPS
Ask the moment Lyell Immunopharma, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Lyell Immunopharma, Inc. report Q2 2025 earnings?
- Lyell Immunopharma, Inc. (LYEL) reported Q2 2025 earnings on August 12, 2025 before market open.
- What were Lyell Immunopharma, Inc.'s Q2 2025 revenue and EPS?
- Lyell Immunopharma, Inc. reported revenue of $8.0K and eps of $-2.89 for Q2 2025.
- Did Lyell Immunopharma, Inc. beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $4.0K by $4.0K. EPS beat the consensus estimate of $-3.80 by $0.91.
- How did Lyell Immunopharma, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 38.5% from $13.0K a year earlier and eps declined 1505.6% from $-0.18.
- Where can I find Lyell Immunopharma, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001806952-25-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.